Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium
More studies will be needed to understand what the white blood cells are doing and whether they pose long-term risk.
More studies will be needed to understand what the white blood cells are doing and whether they pose long-term risk.
Acoramidis becomes the second drug ever approved for this condition, based on the results of the ATTRibute-CM trial.
This month: Sleep talking and stroke risk, pregnancy-related VTE recurrence, long-term tirzepatide benefits, and more.
(UPDATED) Pooled data from three NUDGE-FLU trials show targeted messaging about CV benefits is helpful in these high-risk patients.
The prevalence of obesity and overweight is extraordinarily high. Unsurprisingly, deaths related to obesity are on the rise, too.
(UPDATED) The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable results.
Britton Scheuermann, MS, shares how researchers validated the new tool’s ability to predict 10-year risk of mortality.
In the Swedish survey, many patients said their sexual health was impaired, but few got the information they wanted.
Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.
Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.
Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.